Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas
Authors:
- T.A OlsonTOT.A Olson
- J.J GoswitzJGJ.J Goswitz
- D MohanrajDMD Mohanraj
- L.B TwiggsLTL.B Twiggs
- L.F CarsonLCL.F Carson
- S RamakrishnanSRS Ramakrishnan
- 1 December 1997
- journal article
- clinical trial
- Published by Elsevier in Cancer Letters
- Vol. 121 (2) , 169-175
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Tumor angiogenesis: An independent prognostic parameter in cervical cancerAmerican Journal of Obstetrics and Gynecology, 1996
- Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospectsJournal of Molecular Medicine, 1995
- Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast CancerJapanese Journal of Cancer Research, 1994
- Vascular permeability factor (VPF, VEGF) in tumor biologyCancer and Metastasis Reviews, 1993
- Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancerCell Biochemistry and Biophysics, 1993
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- Vascular Endothelial Growth Factor is Expressed in Rat Corpus LuteumEndocrinology, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989